Loading insider details...
Beta
Latest Form 4 (Sep 21, 2026): Exercise/Conversion of 3,982 ELVN shares, $59.1K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 21, 2026 | Enliven Therapeutics, Inc. (ELVN) | Exercise/Conversion | 3,982 | $59.1K |
| Aug 19, 2026 | Enliven Therapeutics, Inc. (ELVN) | Sale | 4,630 | $270.2K |
| Jul 21, 2026 | Enliven Therapeutics, Inc. (ELVN) | Exercise/Conversion | 1,072 | $2.7K |
| Jun 22, 2026 | Enliven Therapeutics, Inc. (ELVN) | Exercise/Conversion | 6,018 | $14.9K |
| Mar 10, 2026 | Enliven Therapeutics, Inc. (ELVN) | Sale | 10,000 | $295.8K |
| Feb 18, 2026 | Enliven Therapeutics, Inc. (ELVN) | Grant/Award | 25,000 | n/a |
| Dec 23, 2025 | Enliven Therapeutics, Inc. (ELVN) | Exercise/Conversion | 13,000 | $32.2K |
| Oct 1, 2025 | Enliven Therapeutics, Inc. (ELVN) | Exercise/Conversion | 3,250 | $8.1K |
| Aug 29, 2025 | Enliven Therapeutics, Inc. (ELVN) | Exercise/Conversion | 3,250 | $8.1K |
| Jul 30, 2025 | Enliven Therapeutics, Inc. (ELVN) | Exercise/Conversion | 3,250 | $8.1K |